Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

A Couple-Based Bonding Program During Pregnancy: Testing the Maternal-Fetal Attachment Kit (MaKit) to Strengthen Emotional Connection Between Expectant Mothers and Their Unborn Babies in Antenatal Care ((MaKit))

2 de julio de 2026 actualizado por: Endang Koni Suryaningsih, Universitas Aisyiyah Yogyakarta

Effectiveness of the Maternal-Fetal Attachment Kit (MaKit) on Maternal-Fetal Attachment Among Expectant Couples Attending Antenatal Care: A Quasi-Experimental Study

Understanding the Maternal-Fetal Attachment Kit (MaKit) Study What is this study about? This study looked at whether a special program called the Maternal-Fetal Attachment Kit (MaKit) could help pregnant women feel more emotionally connected to their unborn babies. The program was designed to involve both the mother and her partner, making it a couple-based experience during pregnancy.

Why was this study done? Feeling emotionally bonded to an unborn baby during pregnancy is very important. It supports the mother's well-being and helps parents feel more ready for parenthood. However, most routine pregnancy check-ups (antenatal care) focus mainly on the physical health of the mother and baby, with little attention given to emotional bonding or involving the partner. This study aimed to fill that gap.

Who took part in this study?

Thirty pregnant women and their partners attending a primary antenatal care clinic in Indonesia took part in this study. They were divided into two groups:

Intervention group (15 couples): Received standard antenatal care plus the MaKit program.

Control group (15 couples): Received standard antenatal care only.

The study was conducted between March and May 2024. What is MaKit? MaKit is a psychosocial intervention kit designed to be used at home by expectant couples. It provides structured activities that encourage both parents to reflect on and strengthen their emotional bond with their unborn baby. It is designed to complement - not replace - routine antenatal care provided by midwives.

What did the study find? After the intervention, mothers in the MaKit group showed significantly higher emotional bonding scores with their unborn babies compared to mothers in the control group (68.5 vs. 62.7 out of a possible score). This difference was meaningful and statistically significant, suggesting that MaKit genuinely helped improve the mother-baby emotional connection.

What does this mean for patients and families? If you are pregnant, emotional bonding with your baby during pregnancy matters - and it is something you and your partner can actively nurture together. Programs like MaKit offer simple, structured ways to do this at home, alongside your regular antenatal visits. Involving your partner in this process may also strengthen your relationship and your shared readiness for parenthood.

What does this mean for health care providers? MaKit shows promise as a practical, low-cost psychosocial tool that midwives and antenatal care providers can recommend to expectant couples. Integrating such interventions into standard antenatal care could support a more holistic, family-centered model of care - addressing not just the physical, but also the emotional dimensions of pregnancy. This is especially relevant in low- and middle-income settings where psychosocial support during pregnancy is often limited.

What are the limitations? This was a small study involving only 30 couples at a single clinic in Indonesia. While the results are promising, larger studies across different settings are needed to confirm these findings and explore the long-term effects of MaKit on parenting and child development outcomes.

Key Takeaway The Maternal-Fetal Attachment Kit (MaKit) is a promising, couple-focused program that can help expectant mothers feel more emotionally connected to their unborn babies when used alongside routine antenatal care. It is simple, home-based, and designed to involve both parents in the bonding journey.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Special Region of Yogyakarta
      • Sleman, Special Region of Yogyakarta, Indonesia, 55292
        • Klinik Aisyiyah Moyudan

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • pregnant women 16-36 weeks' gestation with a singleton pregnancy, i
  • in marital union,
  • attending the antenatal care visit with their husband,
  • willing partner to participate in the intervention, and
  • able to communicate in Indonesian

Exclusion Criteria:

  • women ≥37 weeks' gestation (as they would likely deliver before completing the four-week intervention and follow-up).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación Secuencial
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Maternal-fetal attachment Kit
Participants in this group received standard antenatal care plus the Maternal-Fetal Attachment Kit (MaKit), a structured, brief couple-focused psychosocial intervention. MaKit was introduced at a single midwife-led session during a routine antenatal visit (approximately 30 minutes) at ≥16 weeks gestation. The kit consists of four components: (1) a visual guidebook (32 pages) covering prenatal attachment, fetal development, and bonding strategies; (2) a structured couple activity booklet with six guided home-based bonding exercises (e.g., fetal movement awareness, joint relaxation, shared letter-writing to the baby); (3) a partner affirmation card set with structured prompts for daily supportive communication; and (4) a reflective diary for recording daily thoughts, feelings, and attachment-related behaviours. Following the introductory session, couples independently practised the home-based activities over four weeks.
makit
Sin intervención: No intervention
Participants in this group received standard antenatal care only, as routinely provided at the 'Aisyiyah Moyudan Clinic, Sleman Regency, Indonesia. No additional psychosocial intervention or bonding-related materials were provided. Maternal-fetal attachment was assessed at baseline and at a follow-up antenatal visit approximately four weeks later, under identical measurement conditions as the intervention group.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Maternal-Fetal Attachment as Measured by the Prenatal Attachment Inventory (PAI)
Periodo de tiempo: up to 4 weeks
Maternal-fetal attachment will be assessed using the Prenatal Attachment Inventory (PAI), a 21-item self-report questionnaire developed by Muller (1993) to measure the intensity of a pregnant woman's emotional attachment to her unborn child. Each item is rated on a 4-point Likert scale, yielding a total score ranging from 21 to 84, with higher scores indicating stronger prenatal attachment. The PAI assesses maternal thoughts, feelings, and behaviors directed toward the fetus, such as attributing characteristics to the unborn child and engaging in interactive behaviors (e.g., talking to or touching the abdomen). The instrument will be administered [before and after the intervention / at baseline and follow-up] to evaluate changes in attachment scores.
up to 4 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de marzo de 2025

Finalización primaria (Actual)

25 de mayo de 2025

Finalización del estudio (Actual)

26 de mayo de 2025

Fechas de registro del estudio

Enviado por primera vez

24 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

2 de julio de 2026

Publicado por primera vez (Actual)

9 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • No. 4335/KEP-UNISA/III/2025)
  • Nomor: 0258.407/I.3/D/2025 (Otro número de subvención/financiamiento: Majelis Pendidikan Tinggi Penelitian dan Pengembangan Pimpinan Pusat (Diktilitbang) Pimpinan Pusat Muhammadiyah.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir